Literature DB >> 22228470

Activation of PKR/eIF2α signaling cascade is associated with dihydrotestosterone-induced cell cycle arrest and apoptosis in human liver cells.

Rongyang Dai1, Dongmei Yan, Juan Li, Shaokun Chen, Youping Liu, Run Chen, Chunyan Duan, Mei Wei, Hong Li, Tao He.   

Abstract

Androgen receptor (AR) signaling plays an important role in the development and progression of several liver diseases, including hepatocellular carcinoma (HCC) and non-alcoholic fatty liver disease (NAFLD). Dihydrotestosterone (DHT) is the active metabolite of the major circulating androgen, testosterone. In this study, we investigated the effect of DHT on human liver cells. We found that DHT not only induces cell cycle arrest but also initiates apoptosis in androgen-sensitive liver cells, such as SMMC-7721 and L02. Importantly, DHT/AR induces the activation of RNA-dependent protein kinase (PKR)/eukaryotic initiation factor-2 alpha (eIF2α) cascades in androgen-sensitive liver cells. PKR/eIF2α activation-induced growth arrest and DNA damage-inducible gene 153 (GADD153) and heat shock protein 27 (Hsp27) expression contribute to cell cycle arrest in response to DHT. It is notable that DHT administration results in androgen-sensitive liver cells apoptosis, at least in part, through PKR/eIF2α/GADD153 cascades. These results suggest that the androgen/AR pathway plays a pivotal role in liver cell growth and apoptosis regulating, whose deregulation might be involved in the pathogenesis of liver diseases.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22228470     DOI: 10.1002/jcb.24051

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

Review 1.  Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Authors:  Carly E Kelley; Ann J Brown; Anna Mae Diehl; Tracy L Setji
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 2.  Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Jay Reddy
Journal:  Int J Cardiol       Date:  2014-10-18       Impact factor: 4.164

Review 3.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

4.  Relevance of low testosterone to non-alcoholic fatty liver disease.

Authors:  Avni Mody; Donna White; Fasiha Kanwal; Jose M Garcia
Journal:  Cardiovasc Endocrinol       Date:  2015-09-01

5.  Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German/Austrian/Swiss obesity registry APV.

Authors:  Susanne Greber-Platzer; Alexandra Thajer; Svenja Bohn; Annette Brunert; Felicitas Boerner; Wolfgang Siegfried; Andreas Artlich; Anja Moeckel; Hildegunde Waldecker-Krebs; Sophie Pauer; Reinhard W Holl
Journal:  BMC Pediatr       Date:  2019-09-12       Impact factor: 2.125

6.  Androgen signaling promotes translation of TMEFF2 in prostate cancer cells via phosphorylation of the α subunit of the translation initiation factor 2.

Authors:  Ryan F Overcash; Vesna A Chappell; Thomas Green; Christopher B Geyer; Adam S Asch; Maria J Ruiz-Echevarría
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

7.  Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS).

Authors:  Ancha Baranova; Thuy Phuong Tran; Arian Afendy; Lei Wang; Amirhossein Shamsaddini; Rohini Mehta; Vikas Chandhoke; Aybike Birerdinc; Zobair M Younossi
Journal:  J Transl Med       Date:  2013-05-31       Impact factor: 5.531

8.  FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer.

Authors:  Meiting Qiu; Wei Bao; Jingyun Wang; Tingting Yang; Xiaoying He; Yun Liao; Xiaoping Wan
Journal:  BMC Cancer       Date:  2014-02-11       Impact factor: 4.430

Review 9.  The androgen receptor as an emerging target in hepatocellular carcinoma.

Authors:  Tatsuo Kanda; Osamu Yokosuka
Journal:  J Hepatocell Carcinoma       Date:  2015-06-26

10.  Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma.

Authors:  Lei Lv; Yujia Zhao; Qinqin Wei; Ye Zhao; Qiyi Yi
Journal:  Cancer Cell Int       Date:  2020-06-03       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.